BioUK® Guides showcase the expertise of our corporate partners and members, giving members access to practical insights and resources. Each guide is designed to help you save time and money, make valuable connections, and secure investment opportunities to drive growth.
Pre-IND enabling activities: Understanding the Pre-IND Phase through to First-in-Human (FIH) Studies
By ThermoFisher Scientific
Before submitting an IND/IMPD, biotechs must generate key IND-enabling data – nonclinical safety, CMC, and preclinical efficacy – while building a clear clinical and regulatory plan for first-in-human studies.
An IND package includes safety and PK/PD data, manufacturing details, and clinical protocols. Because success depends on tight coordination across nonclinical, CMC, clinical, and regulatory teams, companies should start planning early to ensure a smooth path into human trials.
Supplier Consolidation Process: A streamlined 5-step approach
By BioUK (UK) Ltd
Supplier consolidation helps organisations cut costs, boost efficiency, and improve quality by streamlining their supplier base.
The guide outlines five key steps: understand your current supplier landscape, set clear consolidation goals with stakeholders, rigorously evaluate and select the best long-term suppliers, create strong transition and risk-mitigation plans, and continually monitor and optimise supplier performance.
Done well, consolidation strengthens relationships, reduces risk, and drives greater overall value.
Insurance 101: For Life Science Businesses
By Partners&
Insurance forms part of the building blocks of financial protection for any company. It can be a confusing world to navigate, especially when it comes to the specialist needs of science and technology businesses.
Partners& have created this guide as a convenient, plain-English explanation of essential insurance elements for your business – a route map to financial resilience for science and tech organisations.
Intellectual Property: A Brief Guide
By Venner Shipley
Venner Shipley help innovators protect and leverage their intangible assets – such as inventions, brands, designs and creative works – through patents, trade marks, design rights and copyright.
These IP rights can safeguard market space, generate income, enhance business value and support investment, while also helping organisations avoid infringing others’ rights. This brief guide outlines the key types of IP protection, how they work, and why managing IP effectively is essential for commercial success.
Funding Your Venture: A streamlined 5‑step approach for early-stage companies
By Penningtons Manches Cooper
Early-stage fundraising involves more than simply securing capital. Founders must identify suitable investors, structure investments carefully, and consider options such as convertible instruments and non-dilutive funding. Preserving eligibility for SEIS/EIS relief and maintaining flexibility for future investment rounds are also key considerations.
What Investors Want
By BioUK
This Go2Guide guide has been created for R&D SME leaders in life sciences, and is intended to optimise the chance of building a successful and fruitful relationship journey with investors such that, subject to the technology and leadership team being strong, the chances of securing investment may be higher (than without).
Navigating Data Protection Compliance
By BDO
Data protection is a critical consideration for life sciences organisations, particularly as they progress into clinical development and begin processing increasing volumes of patient data. With evolving global regulations and the growing financial and reputational risks of non-compliance, knowing where to start can be challenging. Here are five key steps to help you get started.
